annual current liabilities:
$15.91M-$9.98M(-38.54%)Summary
- As of today (August 22, 2025), ELVN annual total current liabilities is $15.91 million, with the most recent change of -$9.98 million (-38.54%) on December 31, 2024.
- During the last 3 years, ELVN annual current liabilities has risen by +$10.16 million (+176.64%).
- ELVN annual current liabilities is now -38.54% below its all-time high of $25.89 million, reached on December 31, 2023.
Performance
ELVN Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$15.21M+$1.24M(+8.87%)Summary
- As of today (August 22, 2025), ELVN quarterly total current liabilities is $15.21 million, with the most recent change of +$1.24 million (+8.87%) on June 30, 2025.
- Over the past year, ELVN quarterly current liabilities has dropped by -$6.89 million (-31.19%).
- ELVN quarterly current liabilities is now -41.26% below its all-time high of $25.89 million, reached on December 31, 2023.
Performance
ELVN quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ELVN Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.5% | -31.2% |
| 3 y3 years | +176.6% | +360.7% |
| 5 y5 years | +279.1% | +213.8% |
ELVN Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.5% | +769.7% | -41.3% | +736.7% |
| 5 y | 5-year | -38.5% | +769.7% | -41.3% | +736.7% |
| alltime | all time | -38.5% | +1826.8% | -41.3% | +736.7% |
ELVN Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $15.21M(+8.9%) |
| Mar 2025 | - | $13.97M(-12.2%) |
| Dec 2024 | $15.91M(-38.5%) | $15.91M(-6.5%) |
| Sep 2024 | - | $17.03M(-23.0%) |
| Jun 2024 | - | $22.11M(-11.7%) |
| Mar 2024 | - | $25.03M(-3.3%) |
| Dec 2023 | $25.89M(+1315.0%) | $25.89M(+114.4%) |
| Sep 2023 | - | $12.08M(+32.1%) |
| Jun 2023 | - | $9.15M(-16.4%) |
| Mar 2023 | - | $10.94M(+497.9%) |
| Dec 2022 | $1.83M | $1.83M(+0.7%) |
| Sep 2022 | - | $1.82M(-44.9%) |
| Jun 2022 | - | $3.30M(-54.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $7.22M(+0.2%) |
| Dec 2021 | $5.75M(-7.9%) | - |
| Dec 2021 | - | $7.21M(+0.3%) |
| Sep 2021 | - | $7.19M(+3.1%) |
| Jun 2021 | - | $6.97M(+26.7%) |
| Mar 2021 | - | $5.50M(-11.9%) |
| Dec 2020 | $6.25M(+48.8%) | $6.25M(+17.6%) |
| Sep 2020 | - | $5.31M(+9.5%) |
| Jun 2020 | - | $4.85M(-2.0%) |
| Mar 2020 | - | $4.95M |
| Dec 2019 | $4.20M(+129.1%) | - |
| Dec 2018 | $1.83M(+121.8%) | - |
| Dec 2017 | $826.00K | - |
FAQ
- What is Enliven Therapeutics, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual current liabilities year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly current liabilities year-on-year change?
What is Enliven Therapeutics, Inc. annual total current liabilities?
The current annual current liabilities of ELVN is $15.91M
What is the all time high annual current liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual total current liabilities is $25.89M
What is Enliven Therapeutics, Inc. annual current liabilities year-on-year change?
Over the past year, ELVN annual total current liabilities has changed by -$9.98M (-38.54%)
What is Enliven Therapeutics, Inc. quarterly total current liabilities?
The current quarterly current liabilities of ELVN is $15.21M
What is the all time high quarterly current liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly total current liabilities is $25.89M
What is Enliven Therapeutics, Inc. quarterly current liabilities year-on-year change?
Over the past year, ELVN quarterly total current liabilities has changed by -$6.89M (-31.19%)